TY - JOUR
KW - adherence
KW - chronic obstructive pulmonary disease (COPD) treatment
KW - comparative effectiveness
KW - inhaled corticosteroid/long-actingβ2-agonist (ICS/LABA) dual therapy
KW - long-acting muscarinic antagonist (LAMA)/LABA dual therapy
AU - A. Czira
AU - G. Requena
AU - V. Banks
AU - R. Wood
AU - T. Tritton
AU - C. Castillo
AU - J. Yeap
AU - R. Wild
AU - C. Compton
AU - K. Rothnie
AU - F. Herth
AU - J. Quint
AU - A. Ismaila
AD - R&D Global Medical, GSK, Brentford, Middlesex, UK.
Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK.
Department of Pulmonology and Respiratory Care Medicine, Thoraxklinik at the University of Heidelberg, Heidelberg, Germany.
Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research DZL, Heidelberg, Germany.
National Heart and Lung Institute, Imperial College London, London, UK.
Value Evidence and Outcomes, GSK, Collegeville, PA, USA.
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
AN - 37155496
BT - Int J Chron Obstruct Pulmon Dis
C2 - PMC10122847
DO - 10.2147/copd.s405498
DP - NLM
ET - 2023/05/08
LA - eng
N1 - 1178-2005
Czira, Alexandrosz
Orcid: 0000-0002-3395-6186
Requena, Gema
Orcid: 0000-0002-1889-6656
Banks, Victoria
Orcid: 0000-0002-0087-7641
Wood, Robert
Orcid: 0000-0002-6977-435x
Tritton, Theo
Castillo, Catherine M
Orcid: 0000-0002-7204-6169
Yeap, Jie
Wild, Rosie
Orcid: 0000-0002-9963-6441
Compton, Chris
Orcid: 0000-0002-7564-5343
Rothnie, Kieran J
Orcid: 0000-0003-4279-1624
Herth, Felix
Orcid: 0000-0002-7638-2506
Quint, Jennifer K
Orcid: 0000-0003-0149-4869
Ismaila, Afisi S
Orcid: 0000-0002-2876-8308
Journal Article
New Zealand
Int J Chron Obstruct Pulmon Dis. 2023 Apr 19;18:643-659. doi: 10.2147/COPD.S405498. eCollection 2023.
PY - 2023
SN - 1176-9106
SP - 643
EP - 659
T2 - Int J Chron Obstruct Pulmon Dis
TI - Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England
VL - 18
ER -